Analgesics Market Overview
Analgesics, also called painkillers, are medications that relieve different types of pain, from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain. The global Analgesics market has been rising continuously due to the growing incidence of cancer and the increasing chronic diseases across the world. The increasing therapeutic benefits offered by analgesics, in addition to effective and fast relief from pain, have remarkably boosted the demand for analgesics in the years ahead. Additionally, the development of innovative drugs and increasing awareness about these treatment options have also significantly supported the growth of the Analgesics market.
Furthermore, rising recurring aches and pains due to growing the prevalence of cancer, cardiovascular disease, arthritis, and other chronic and acute diseases has fuelled the demand for analgesics. Additionally, the increasing prevalence of pain, the rising effective treatment options, a surge in the aging population, and the growing acceptance of analgesics by a larger target audience are some noteworthy factors positively impacting the growth of the global Analgesics market.
Covid-19 Impact on Analgesics Market
In addition, the current Analgesics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Analgesics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Analgesics Market Segment Overview
Based on Drug Type, Prescription analgesics currently represent the most popular drug type across the world. Based on the drug class, the Opioids segment dominates the market as they are extensively used in cancer pain management and end-stage diseases in which palliative care is required. In addition, Oral is the most common route of administration (ROA) since it is considered to be one of the safest ROA and requires minimal to no medical assistance. At present, musculoskeletal pain accounts for the maximum share of the global market. It is most often caused by an injury to the bones, joints, muscles, tendons, ligaments, or nerves. Currently, by application, the Internal segment exhibit a clear dominance in the market. They are intended for internal use and are either taken by mouth in the form of pills and liquids or inserted into the rectum in suppository form.
Analgesics Market, By Drug Type
· Prescription
· Over the counter (OTC)
Analgesics Market, By Drug Class
· Opioids
· NSAID
· Others
Analgesics Market, By Route of Administration
· Oral
· Parenteral
· Topical
· Transdermal
· Rectal
Analgesics Market, By Pain Type
· Musculoskeletal
· Surgical and Trauma
· Cancer
· Neuropathic
· Migraine
· Obstetrical
· Fibromyalgia
· Pain due to Burns
· Dental/Facial
· Pediatric
· Others
Analgesics Market, By Application
· Internal
· External
Analgesics Regional Overview
In terms of region, North America is at the forefront in the global Analgesics market and is predicted to continue to retain its lead position through the forecast period. New regulatory changes in the U.S., with new marketing strategies by analgesics companies, have significantly benefited this regional market. In addition to this, the increasing occurrence of aches and pains, the rise in the average age of the population, and an alarming rate of obesity are other factors propelling the growth of the market in this region. The European analgesics market is also estimated to expand in the coming years due to the rapid commercialization of new drugs and an increasingly old age population. The market of the Asia Pacific is projected to grow at the fastest rate in the forecast period. The analgesics market in developing countries, such as China and India, has many growth opportunities because of the availability of cheap raw materials and an economical workforce. Also, the global analgesics manufacturers are relocating their facilities into developing countries by agreements or acquisitions with local players.
Analgesics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Analgesics Market, Key Players
· Eli Lilly and Company
· Teva Pharmaceutical Industries Ltd.
· Bayer AG
· F. Hoffmann-La Roche Ltd.
· Pfizer Inc.
· Endo Pharmaceuticals
· Reckitt Benckiser plc
· Bristol-Myers Squibb
· Sanofi
· Johnson & Johnson
· Novartis AG
· GlaxoSmithKline PLC
Analgesics, also called painkillers, are medications that relieve different types of pain, from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain. The global Analgesics market has been rising continuously due to the growing incidence of cancer and the increasing chronic diseases across the world. The increasing therapeutic benefits offered by analgesics, in addition to effective and fast relief from pain, have remarkably boosted the demand for analgesics in the years ahead. Additionally, the development of innovative drugs and increasing awareness about these treatment options have also significantly supported the growth of the Analgesics market.
Furthermore, rising recurring aches and pains due to growing the prevalence of cancer, cardiovascular disease, arthritis, and other chronic and acute diseases has fuelled the demand for analgesics. Additionally, the increasing prevalence of pain, the rising effective treatment options, a surge in the aging population, and the growing acceptance of analgesics by a larger target audience are some noteworthy factors positively impacting the growth of the global Analgesics market.
Covid-19 Impact on Analgesics Market
In addition, the current Analgesics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Analgesics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Analgesics Market Segment Overview
Based on Drug Type, Prescription analgesics currently represent the most popular drug type across the world. Based on the drug class, the Opioids segment dominates the market as they are extensively used in cancer pain management and end-stage diseases in which palliative care is required. In addition, Oral is the most common route of administration (ROA) since it is considered to be one of the safest ROA and requires minimal to no medical assistance. At present, musculoskeletal pain accounts for the maximum share of the global market. It is most often caused by an injury to the bones, joints, muscles, tendons, ligaments, or nerves. Currently, by application, the Internal segment exhibit a clear dominance in the market. They are intended for internal use and are either taken by mouth in the form of pills and liquids or inserted into the rectum in suppository form.
Analgesics Market, By Drug Type
· Prescription
· Over the counter (OTC)
Analgesics Market, By Drug Class
· Opioids
· NSAID
· Others
Analgesics Market, By Route of Administration
· Oral
· Parenteral
· Topical
· Transdermal
· Rectal
Analgesics Market, By Pain Type
· Musculoskeletal
· Surgical and Trauma
· Cancer
· Neuropathic
· Migraine
· Obstetrical
· Fibromyalgia
· Pain due to Burns
· Dental/Facial
· Pediatric
· Others
Analgesics Market, By Application
· Internal
· External
Analgesics Regional Overview
In terms of region, North America is at the forefront in the global Analgesics market and is predicted to continue to retain its lead position through the forecast period. New regulatory changes in the U.S., with new marketing strategies by analgesics companies, have significantly benefited this regional market. In addition to this, the increasing occurrence of aches and pains, the rise in the average age of the population, and an alarming rate of obesity are other factors propelling the growth of the market in this region. The European analgesics market is also estimated to expand in the coming years due to the rapid commercialization of new drugs and an increasingly old age population. The market of the Asia Pacific is projected to grow at the fastest rate in the forecast period. The analgesics market in developing countries, such as China and India, has many growth opportunities because of the availability of cheap raw materials and an economical workforce. Also, the global analgesics manufacturers are relocating their facilities into developing countries by agreements or acquisitions with local players.
Analgesics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Analgesics Market, Key Players
· Eli Lilly and Company
· Teva Pharmaceutical Industries Ltd.
· Bayer AG
· F. Hoffmann-La Roche Ltd.
· Pfizer Inc.
· Endo Pharmaceuticals
· Reckitt Benckiser plc
· Bristol-Myers Squibb
· Sanofi
· Johnson & Johnson
· Novartis AG
· GlaxoSmithKline PLC
Analgesics Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Type
- 5.2.1. Prescription
- 5.2.2. Over the counter (OTC)
- 5.3. Market Analysis, Insights and Forecast – By Drug Class
- 5.3.1. Opioids
- 5.3.2. NSAID
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Route of Administration
- 5.4.1. Oral
- 5.4.2. Parenteral
- 5.4.3. Topical
- 5.4.4. Transdermal
- 5.4.5. Rectal
- 5.5. Market Analysis, Insights and Forecast – By Pain Type
- 5.5.1. Musculoskeletal
- 5.5.2. Surgical and Trauma
- 5.5.3. Cancer
- 5.5.4. Neuropathic
- 5.5.5. Migraine
- 5.5.6. Obstetrical
- 5.5.7. Fibromyalgia
- 5.5.8. Pain due to Burns
- 5.5.9. Dental/Facial
- 5.5.10. Pediatric
- 5.5.11. Others
- 5.6. Market Analysis, Insights and Forecast – By Application
- 5.6.1. Internal
- 5.6.2. External
- 5.7. Market Analysis, Insights and Forecast – By Region
- 5.7.1. North America
- 5.7.2. Europe
- 5.7.3. Asia Pacific
- 5.7.4. Latin America, Middle East and Africa
6. North America Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Drug Type
- 6.2.1. Prescription
- 6.2.2. Over the counter (OTC)
- 6.3. Market Analysis, Insights and Forecast – By Drug Class
- 6.3.1. Opioids
- 6.3.2. NSAID
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast – By Route of Administration
- 6.4.1. Oral
- 6.4.2. Parenteral
- 6.4.3. Topical
- 6.4.4. Transdermal
- 6.4.5. Rectal
- 6.5. Market Analysis, Insights and Forecast – By Pain Type
- 6.5.1. Musculoskeletal
- 6.5.2. Surgical and Trauma
- 6.5.3. Cancer
- 6.5.4. Neuropathic
- 6.5.5. Migraine
- 6.5.6. Obstetrical
- 6.5.7. Fibromyalgia
- 6.5.8. Pain due to Burns
- 6.5.9. Dental/Facial
- 6.5.10. Pediatric
- 6.5.11. Others
- 6.6. Market Analysis, Insights and Forecast – By Application
- 6.6.1. Internal
- 6.6.2. External
- 6.7. Market Analysis, Insights and Forecast – By Country
- 6.7.1. U.S.
- 6.7.2. Canada
7. Europe Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Drug Type
- 7.2.1. Prescription
- 7.2.2. Over the counter (OTC)
- 7.3. Market Analysis, Insights and Forecast – By Drug Class
- 7.3.1. Opioids
- 7.3.2. NSAID
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast – By Route of Administration
- 7.4.1. Oral
- 7.4.2. Parenteral
- 7.4.3. Topical
- 7.4.4. Transdermal
- 7.4.5. Rectal
- 7.5. Market Analysis, Insights and Forecast – By Pain Type
- 7.5.1. Musculoskeletal
- 7.5.2. Surgical and Trauma
- 7.5.3. Cancer
- 7.5.4. Neuropathic
- 7.5.5. Migraine
- 7.5.6. Obstetrical
- 7.5.7. Fibromyalgia
- 7.5.8. Pain due to Burns
- 7.5.9. Dental/Facial
- 7.5.10. Pediatric
- 7.5.11. Others
- 7.6. Market Analysis, Insights and Forecast – By Application
- 7.6.1. Internal
- 7.6.2. External
- 7.7. Market Analysis, Insights and Forecast – By Country
- 7.7.1. UK
- 7.7.2. Germany
- 7.7.3. France
- 7.7.4. Italy
- 7.7.5. Spain
- 7.7.6. Russia
- 7.7.7. Rest of Europe
8. Asia Pacific Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Drug Type
- 8.2.1. Prescription
- 8.2.2. Over the counter (OTC)
- 8.3. Market Analysis, Insights and Forecast – By Drug Class
- 8.3.1. Opioids
- 8.3.2. NSAID
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast – By Route of Administration
- 8.4.1. Oral
- 8.4.2. Parenteral
- 8.4.3. Topical
- 8.4.4. Transdermal
- 8.4.5. Rectal
- 8.5. Market Analysis, Insights and Forecast – By Pain Type
- 8.5.1. Musculoskeletal
- 8.5.2. Surgical and Trauma
- 8.5.3. Cancer
- 8.5.4. Neuropathic
- 8.5.5. Migraine
- 8.5.6. Obstetrical
- 8.5.7. Fibromyalgia
- 8.5.8. Pain due to Burns
- 8.5.9. Dental/Facial
- 8.5.10. Pediatric
- 8.5.11. Others
- 8.6. Market Analysis, Insights and Forecast – By Application
- 8.6.1. Internal
- 8.6.2. External
- 8.7. Market Analysis, Insights and Forecast – By Country
- 8.7.1. China
- 8.7.2. India
- 8.7.3. Japan
- 8.7.4. Australia
- 8.7.5. South East Asia
- 8.7.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Drug Type
- 9.2.1. Prescription
- 9.2.2. Over the counter (OTC)
- 9.3. Market Analysis, Insights and Forecast – By Drug Class
- 9.3.1. Opioids
- 9.3.2. NSAID
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast – By Route of Administration
- 9.4.1. Oral
- 9.4.2. Parenteral
- 9.4.3. Topical
- 9.4.4. Transdermal
- 9.4.5. Rectal
- 9.5. Market Analysis, Insights and Forecast – By Pain Type
- 9.5.1. Musculoskeletal
- 9.5.2. Surgical and Trauma
- 9.5.3. Cancer
- 9.5.4. Neuropathic
- 9.5.5. Migraine
- 9.5.6. Obstetrical
- 9.5.7. Fibromyalgia
- 9.5.8. Pain due to Burns
- 9.5.9. Dental/Facial
- 9.5.10. Pediatric
- 9.5.11. Others
- 9.6. Market Analysis, Insights and Forecast – By Application
- 9.6.1. Internal
- 9.6.2. External
- 9.7. Market Analysis, Insights and Forecast – By Country
- 9.7.1. Brazil
- 9.7.2. Saudi Arabia
- 9.7.3. UAE
- 9.7.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Eli Lilly and Company
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Teva Pharmaceutical Industries Ltd.
- 10.6. Bayer AG
- 10.7. F. Hoffmann-La Roche Ltd.
- 10.8. Pfizer Inc.
- 10.9. Endo Pharmaceuticals
- 10.10. Reckitt Benckiser plc
- 10.11. Bristol-Myers Squibb
- 10.12. Sanofi
- 10.13. Johnson & Johnson
- 10.14. Novartis AG
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
